- Home
- ELAB
ELAB
Elevai Labs Inc.
as 04-24-2025 12:35pm EST
Stocks
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | NEWPORT BEACH |
| Market Cap: | 6.6M | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 795.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -78.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.26 - $1064.00 | Next Earning Date: | 05-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Elevai Labs Inc. News
ELAB Breaking Stock News: Dive into ELAB Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 hours ago
Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment
MT Newswires
8 days ago
PMGC Signs Letter of Intent to Purchase Custom IT Packaging Firm; Shares Fall
GlobeNewswire
8 days ago
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company
GlobeNewswire
14 days ago
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
GlobeNewswire
a month ago
PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K
GlobeNewswire
a month ago
NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market
GlobeNewswire
a month ago
Univest Securities, LLC Announces Closing of $1.48 Million Registered Direct Offering for its Client PMGC Holdings Inc. (NASDAQ: ELAB)
GlobeNewswire
a month ago
PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules
Compare ELAB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ELAB Elevai Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.